SABCS Video Perspectives

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

4:00C. Kent Osborne, MD

Please discuss developments in diagnosing breast cancer that were presented at SABCS 2019.

5:39C. Kent Osborne, MD

What notable studies were presented in HER2 positive breast cancer?

1:03C. Kent Osborne, MD

What major advances in breast cancer treatment were presented at the meeting?

1:37C. Kent Osborne, MD

Please discuss developments in breast cancer prevention that were presented at the meeting.

1:54C. Kent Osborne, MD

What were the main takeaways from this year’s symposium?

C. Kent Osborne, MD, is the director of the Dan L. Duncan Comprehensive Cancer Center at Baylor College of Medicine and co-director of the San Antonio Breast Cancer Symposium.

In this video, Osborne discusses:

developments in breast cancer detection with circulating tumor DNA;
novel drugs that have the potential to change routine practice for HER2-positive breast cancer;
major advances in triple negative breast cancer;
pivotal trials in breast cancer prevention; and
the main takeaways from SABCS 2019.